Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs

Bibliography

• Lipinski CA, Lombardo F, Dominy BW, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46(1-3):3-26
   PubMed Web of Science ®Google Scholar
• Wong J, Brugger A, Khare A, Suspensions for intravenous (IV) injection: A review of development, preclinical and clinical aspects. Adv Drug Deliv Rev 2008;60(8):939-54
   PubMed Web of Science ®Google Scholar
• Talegaonkar S AA, Ahmad FJ, Khar RK, Microemulsions: a novel approach to enhanced drug delivery. Recent Pat Drug Deliv Formul 2008;2(3):238-57
   PubMedGoogle Scholar
• Heuschkel S, Goebel A, Neubert RHH. Microemulsions- modern colloidal carrier for dermal and transdermal drug delivery. J Pharm Sci 2008;97(2):603-31
   PubMed Web of Science ®Google Scholar
• Spernath A, Aserin A. Microemulsions as carriers for drugs and nutraceuticals. Adv Colloid Interface Sci 2006;128-130:47-64
   PubMed Web of Science ®Google Scholar
• Bouchemal K, Briançon S, Perrier E, Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation. Int J Pharm 2004;280(1-2):241-51
   PubMedGoogle Scholar
• Anton N, Benoit J-P, Saulnier P. Design and production of nanoparticles formulated from nano-emulsion templates–a review. J Control Release 2008;128(3):185-99
   PubMed Web of Science ®Google Scholar
• Jadhav KR, Shaikh IM, Ambade KW, Kadam VJ. Applications of microemulsion based drug delivery system. Curr Drug Deliv 2006;3:267-73
   PubMedGoogle Scholar
• Jayvadan Patel AS. Self-emulsifying delivery systems for poorly absorbed drugs. Int J Pharm Sci Nanotechnol 2008;1(3):123-8
   Google Scholar
• Patel PA, Chaulang GM, Akolkotkar A, Self emulsifying drug delivery system: a review research. J Pharm Tech 2008;1(4):313-23
   Google Scholar
• Jing-ling T, Jin S, Zhong-Gui H. Self-emulsifying drug delivery systems: strategy for improving oral delivery of poorly soluble drugs. Curr Drug Ther 2007;2:85-93
   Google Scholar
• Kommuru TR, Gurley B, Khan MA, Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm 2001;212(2):233-46
   PubMed Web of Science ®Google Scholar
• Kang BK, Lee JS, Chon SK, Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 2004;274(1-2):65-73
   PubMed Web of Science ®Google Scholar
• Hong JY, Kim JK, Song YK, A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. J Control Release 2006;110(2):332-8
   PubMed Web of Science ®Google Scholar
• Wu W, Wang Y, Que L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur J Pharm Biopharm 2006;63(3):288-94
   PubMed Web of Science ®Google Scholar
• Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur J Pharm Sci 2000;11(Suppl 2):S93-8
   PubMed Web of Science ®Google Scholar
• Shen H, Zhong M. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. J Pharm Pharmacol 2006;58(9):1183-91
   PubMed Web of Science ®Google Scholar
• Tang B, Cheng G, Gu JC, Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms. Drug Discov Today 2008;13(13-14):606-12
   PubMed Web of Science ®Google Scholar
• Pouton CW, Porter CJ. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev 2008;60(6):625-37
   PubMed Web of Science ®Google Scholar
• Ito Y, Kusawake T, Ishida M, Oral solid gentamicin preparation using emulsifier and adsorbent. J Control Release 2005;105(1-2):23-31
   PubMed Web of Science ®Google Scholar
• Christensen KL, Pedersen GP, Kristensen HG. Preparation of redispersible dry emulsions by spray drying. Int J Pharm 2001;212(2):187-94
   PubMedGoogle Scholar
• Hansen T, Holm P, Rohde M, In vivo evaluation of tablets and capsules containing spray-dried o/w-emulsions for oral delivery of poorly soluble drugs. Int J Pharm 2005;293(1-2):203-11
   PubMedGoogle Scholar
• Li F, Wang T, He HB, The properties of bufadienolides-loaded nano-emulsion and submicro-emulsion during lyophilization. Int J Pharm 2008;349(1-2):291-9
   PubMedGoogle Scholar
• Royce A SJ, Shah U, Vishnupad K. Alternative granulation technique: melt granulation. Drug Dev Ind Pharm 1996;22:917-24
   Web of Science ®Google Scholar
• Newton JM, Pinto MR, Podczeck F. The preparation of pellets containing a surfactant or a mixture of mono- and di-gylcerides by extrusion/spheronization. Eur J Pharm Sci 2007;30(3-4):333-42
   PubMed Web of Science ®Google Scholar
• Breitenbach J. Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm 2002;54(2):107-17
   PubMed Web of Science ®Google Scholar
• Pouton CW. Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification. Int J Pharm 1985;27(2-3):335-48
   Google Scholar
• Porter CJH, Charman WN. In vitro assessment of oral lipid based formulations. Adv Drug Deliv Rev 2001;50(Suppl 1):S127-S47
   PubMedGoogle Scholar
• Gershanik T, Benzeno S, Benita S. Interaction of a self-emulsifying lipid drug delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge. Pharm Res 1998;15(6):863-9
   PubMed Web of Science ®Google Scholar
• Kossena GA, Charman WN, Boyd BJ, Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach. J Pharm Sci 2004;93(2):332-48
   PubMed Web of Science ®Google Scholar
• Porter CJH, Kaukonen AM, Taillardat-Bertschinger A, Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. J Pharm Sci 2004;93(5):1110-21
   PubMed Web of Science ®Google Scholar
• Cao Y, Marra M, Anderson BD. Predictive relationships for the effects of triglyceride ester concentration and water uptake on solubility and partitioning of small molecules into lipid vehicles. J Pharm Sci 2004;93(11):2768-79
   PubMed Web of Science ®Google Scholar
• Kossena GA, Boyd BJ, Porter CJH, Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs. J Pharm Sci 2003;92(3):634-48
   PubMed Web of Science ®Google Scholar
• Porter CJH, Pouton CW, Cuine JF, Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev 2008;60(6):673-91
   PubMed Web of Science ®Google Scholar
• Gao P, Morozowich W. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin Drug Deliv 2006;3(1):97-110
   PubMedGoogle Scholar
• Raghavan SL, Trividic A, Davis AF, Crystallization of hydrocortisone acetate: influence of polymers. Int J Pharm 2001;212(2):213-21
   PubMedGoogle Scholar
• Gao P, Rush BD, Pfund WP, Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J Pharm Sci 2003;92(12):2386-98
   PubMed Web of Science ®Google Scholar
• Sek L PC, Kaukonen AM, Charman WN. Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products. J Pharm Pharmacol 2002;54:29-41
   PubMed Web of Science ®Google Scholar
• Christensen JØ, Schultz K, Mollgaard B, Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols. Eur J Pharm Sci 2004;23(3):287-96
   PubMed Web of Science ®Google Scholar
• Nielsen FS, Petersen KB, Mullertz A. Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state. Eur J Pharm Biopharm 2008;69(2):553-62
   PubMed Web of Science ®Google Scholar
• Zangenberg NH, Mullertz A, Kristensen HG, A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium. Eur J Pharm Sci 2001;14(2):115-22
   PubMed Web of Science ®Google Scholar
• Ljusberg-Wahren H, Seier Nielsen F, Brogard M, Enzymatic characterization of lipid-based drug delivery systems. Int J Pharm 2005;298(2):328-32
   PubMedGoogle Scholar
• Dahan A, Hoffman A. Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: correlation with in vivo data and the relationship to intra-enterocyte processes in rats. Pharm Res 2006;23(9):2165-74
   PubMed Web of Science ®Google Scholar
• MacGregor KJ, Embleton JK, Lacy JE, Influence of lipolysis on drug absorption from the gastro-intestinal tract. Adv Drug Deliv Rev 1997;25(1):33-46
   Web of Science ®Google Scholar
• Porter CJH, Kaukonen AM, Boyd BJ, Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation. Pharm Res 2004;21(8):1405-12
   PubMed Web of Science ®Google Scholar
• Cuiné J, Charman W, Pouton C, Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs. Pharm Res 2007;24(4):748-57
   PubMed Web of Science ®Google Scholar
• Trevaskis NL, Charman WN, Porter CJ. Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update. Adv Drug Deliv Rev 2008;60(6):702-16
   PubMed Web of Science ®Google Scholar
• Nordskog BK, Phan CT, Nutting DF, An examination of the factors affecting intestinal lymphatic transport of dietary lipids. Adv Drug Deliv Rev 2001;50(1-2):21-44
   PubMed Web of Science ®Google Scholar
• Nankervis R, Davis SS, Day NH, Intestinal lymphatic transport of three retinoids in the rat after oral administration: effect of lipophilicity and lipid vehicle. Int J Pharm 1996;130(1):57-64
   Google Scholar
• Caliph SM, Charman WN, Porter CJH. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J Pharm Sci 2000;89(8):1073-84
   PubMed Web of Science ®Google Scholar
• Holm R, Mülertz A, Christensen E, Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated triglycerides in lymph-cannulated conscious rats. Eur J Pharm Sci 2001;14(4):331-7
   PubMed Web of Science ®Google Scholar
• Griffin BT, O'Driscoll CM. A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model. J Pharm Pharmacol 2006;58:917-25
   PubMed Web of Science ®Google Scholar
• Hauss DJ, Fogal SE, Ficorilli JV, Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci 1998;87(2):164-9
   PubMed Web of Science ®Google Scholar
• Karpf DM, Holm R, Kristensen HG, Influence of the type of surfactant and the degree of dispersion on the lymphatic transport of halofantrine in conscious rats. Pharm Res 2004;21(8):1413-8
   PubMed Web of Science ®Google Scholar
• Porter CJH, Charman WN. Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev 2001;50(1-2):61-80
   PubMed Web of Science ®Google Scholar
• Dintaman JM, Silverman JA. Inhibition of P-glycoprotein by D-alpha-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS). Pharm Res 1999;16(10):1550-6
   PubMed Web of Science ®Google Scholar
• Chervinsky DS, Brecher ML, Hoelcle MJ. Cremophor EL enhances taxol efficacy in a multidrug resistant C1300 neuroblastoma cell line. Anticancer Res 1993;13:93-6
   PubMed Web of Science ®Google Scholar
• Lo Y-L, Hsu C-Y, Huang J-D. Comparison of effects of surfactants with other MDR reversing agents on intracellular uptake of epirubicin in Caco-2 cell line. Anticancer Res 1998;18:3005-9
   PubMed Web of Science ®Google Scholar
• Yu L, Bridgers A, Polli J, Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability1. Pharm Res 1999;16(12):1812-7
   PubMed Web of Science ®Google Scholar
• Hugger ED, Novak BL, Burton PS, A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. J Pharm Sci 2002;91(9):1991-2002
   PubMed Web of Science ®Google Scholar
• Chiu Y-Y, Higaki K, Neudeck BL, Human jejunal permeability of cyclosporin a: influence of surfactants on P-glycoprotein efflux in caco-2 cells. Pharm Res 2003;20(5):749-56
   PubMed Web of Science ®Google Scholar
• Date AA, Nagarsenker MS. Parenteral microemulsions: an overview. Int J Pharm 2008;355(1-2):19-30
   PubMedGoogle Scholar
• Yuan JS, Ansari M, Samaan M, Linker-based lecithin microemulsions for transdermal delivery of lidocaine. Int J Pharm 2008;349(1-2):130-43
   PubMedGoogle Scholar
• Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 2000;45(1):89-121
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev 2004;56(5):603-18
   PubMed Web of Science ®Google Scholar
• Vandamme TF. Microemulsions as ocular drug delivery systems: recent developments and future challenges. Prog Retin Eye Res 2002;21(1):15-34
   PubMed Web of Science ®Google Scholar
• Kogan A, Garti N. Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci 2006;123-126:369-85
   PubMed Web of Science ®Google Scholar
• Mao C, Wan J, Chen H, Emulsifiers' composition modulates venous irritation of the nanoemulsions as a lipophilic and venous irritant drug delivery system. AAPS PharmSciTech 2009;10:1058-64
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Kabanov AV. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 2008;130(2):98-106
   PubMed Web of Science ®Google Scholar
• Hwang SR, Lim S-J, Park J-S, Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration. Int J Pharm 2004;276(1-2):175-83
   PubMed Web of Science ®Google Scholar
• Zhao X, Liu JP, Zhang X, Enhancement of transdermal delivery of theophylline using microemulsion vehicle. Int J Pharm 2006;327(1-2):58-64
   PubMedGoogle Scholar
• Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986;46(12 Part 1):6387-92
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Multifunctional nanocarriers. Adv Drug Delivery Rev 2006;58(14):1532-55
   PubMed Web of Science ®Google Scholar
• Ohguchi Y, Kawano K, Hattori Y, Selective delivery of folate PEG-linked, nanoemulsion-loaded aclacinomycin A to KB nasopharyngeal cells and xenograft: effect of chain length and amount of folatePEG linker. J Drug Target 2008;16(9):660-7
   PubMed Web of Science ®Google Scholar
• Azevedo CHM, Carvalho JP, Valduga CJ, Plasma kinetics and uptake by the tumor of a cholesterol-rich microemulsion (LDE) associated to etoposide oleate in patients with ovarian carcinoma. Gynecol Oncol 2005;97(1):178-82
   PubMed Web of Science ®Google Scholar
• Rodrigues DG, Maria DA, Fernandes DC, Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studies. Cancer Chemother Pharmacol 2005;55(6):565-76
   PubMed Web of Science ®Google Scholar
• Dias M, Carvalho J, Rodrigues D, Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers. Cancer Chemother Pharmacol 2007;59(1):105-11
   PubMed Web of Science ®Google Scholar
• Romberg B, Oussoren C, Snel C, Effect of liposome characteristics and dose on the pharmacokinetics of liposomes coated with poly(amino acid)s. Pharm Res 2007;24(12):2394-401
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Kojima H, Yamamoto H, Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats. J Control Release 2001;75(1-2):83-91
   PubMed Web of Science ®Google Scholar
• Gao J, Zhong W, He J, Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes. Int J Pharm 2009;374(1-2):145-52
   PubMed Web of Science ®Google Scholar
• Yao J, Zhou JP, Ping QN, Distribution of nobiletin chitosan-based microemulsions in brain following i.v. injection in mice. Int J Pharm 2008;352(1-2):256-62
   PubMedGoogle Scholar
• Forrester JV, Balazs EA. Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 1980;40(3):435-46
   PubMed Web of Science ®Google Scholar
• Otto A, du Plessis J, Wiechers JW. Formulation effects of topical emulsions on transdermal and dermal delivery. Int J Cosmet Sci 2009;31(1):1-19
   PubMedGoogle Scholar
• Jessica S, Yuan EJA. Extended release of lidocaine from linker-based lecithin microemulsions. Int J Pharm 2009;368:63-71
   PubMedGoogle Scholar
• Nornoo AO, Osborne DW, Chow DSL. Cremophor-free intravenous microemulsions for paclitaxel: I: formulation, cytotoxicity and hemolysis. Int J Pharm 2008;349(1-2):108-16
   PubMedGoogle Scholar
• Aparicio RM, José García-Celma M, Pilar Vinardell M, In vitro studies of the hemolytic activity of microemulsions in human erythrocytes. J Pharm Biomed Anal 2005;39(5):1063-7
   PubMed Web of Science ®Google Scholar
• Vicentini FTMC, Simi TRM, Del Ciampo JO, Quercetin in w/o microemulsion: In vitro and in vivo skin penetration and efficacy against UVB-induced skin damages evaluated in vivo. Eur J Pharm Biopharm 2008;69(3):948-57
   PubMed Web of Science ®Google Scholar
• Zhu W, Guo C, Yu A, Microemulsion-based hydrogel formulation of penciclovir for topical delivery. Int J Pharm 2009;378(1-2):152-8
   PubMedGoogle Scholar
• Strickley RG. Currently marketed oral lipid-based dosage forms: drugs products and excipients. In: Dj Hauss, editor, Oral lipid-based formulations: enhancing the bioavailability of poorly water soluble drugs. Informa Healthcare, Inc.: New York; 2007
   Google Scholar
• Schick MJ. Nonionic surfactants. Marcel Dekker, Inc.: New York; 1977
   Google Scholar
• Han M, He CX, Fang QL, A Novel Camptothecin derivative incorporated in nano-carrier induced distinguished improvement in solubility, stability and anti-tumor activity both in vitro and in vivo. Pharm Res 2009;26:926-35
   PubMed Web of Science ®Google Scholar
• Junping W, Takayama K, Nagai Tr, Maitani Y. Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterol. Int J Pharm 2003;251:13-21
   PubMedGoogle Scholar
• Constantinides PP, Lambert KJ, Tustian AK, Formulation development and antitumor activity of a filter-sterilizable emulsion of Paclitaxel. Pharm Res 2000;17:175-82
   PubMed Web of Science ®Google Scholar
• Liu H, Wang Y, Lang Y, Bicontinuous Cyclosporin a loaded Water-AOT/Tween 85-isopropylmyristate microemulsion: Structural characterization and dermal pharmacokinetics in vivo. J Pharm Sci 2009;98:1167-76
   PubMed Web of Science ®Google Scholar
• Elshafeey A, Kamel A, Fathallah M. Utility of nanosized microemulsion for transdermal delivery of tolterodine tartrate: ex-vivo permeation and in-vivo pharmacokinetic studies. Pharm Res 2009;26:2446-53
   PubMed Web of Science ®Google Scholar
• Biruss B, Valenta C. The advantage of polymer addition to a non-ionic oil in water microemulsion for the dermal delivery of progesterone. Int J Pharm 2008;349:269-73
   PubMed Web of Science ®Google Scholar
• Cui J, Yu B, Zhao Y, Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm 2009;371:148-55
   PubMed Web of Science ®Google Scholar
• Patel D, Sawant KK. Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS). Drug Dev Ind Pharm 2007;33:1318-26
   PubMed Web of Science ®Google Scholar
• Cui SX, Nie SF, Li L, Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine. Drug Dev Ind Pharm 2009;35:603-11
   PubMed Web of Science ®Google Scholar
• Woo JS KT, Park JH, Chi SC. Formulation and biopharmaceutical evaluation of silymarin using SMEDDS. Arch Pharm Res 2007;30:82-9
   PubMed Web of Science ®Google Scholar
• Singh A, Chaurasiya A, Awasthi A, Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS). AAPS Pharm Sci Tech 2009;10:906-16
   PubMed Web of Science ®Google Scholar
• Zhang P, Liu Y, Feng N, Xu J. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. Int J Pharm 2008;355:269-76
   PubMed Web of Science ®Google Scholar
• Lu JL, Wang JC, Zhao SX, Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice. Eur J Pharm Biopharm 2008;69:899-907
   PubMed Web of Science ®Google Scholar
• Yi T, Wan J, Xu H, Yang X. A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. Eur J Pharm Biopharm 2008;70:439-44
   PubMed Web of Science ®Google Scholar